Amer Al-Taie

Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model

Jason Gordon, Oliver Darlington, Phil McEwan et al. · PharmacoEconomics · 2020 · 25 citations · Full text

The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom

Lefteris Floros, Antonio Pagliuca, Amer Al-Taie et al. · Journal of Medical Economics · 2019 · 18 citations · Full text

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan

Tetsuya Matsumoto, Oliver Darlington, Ryan Miller et al. · Journal of health economics and outcomes research · 2021 · 12 citations · Full text

Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand

Thitima Kongnakorn, Eszter Tichy, Kirati Kengkla et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 2023 · 11 citations · Full text

Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study

Tetsuya Matsumoto, Akira Yuasa, Ryan Miller et al. · PharmacoEconomics - Open · 2022 · 10 citations · Full text